(Q59616816)
Statements
Zoledronic acid prevents cancer treatment-induced bone loss in premenopausal women receiving adjuvant endocrine therapy for hormone-responsive breast cancer: a report from the Austrian Breast and Colorectal Cancer Study Group (English)
Brigitte Mlineritsch
Gero Luschin-Ebengreuth
Stephan Grampp
Helmut Kaessmann
Marianne Schmid
Christian Menzel
Jutta Claudia Piswanger-Soelkner
Arik Galid
Martina Mittlboeck
Hubert Hausmaninger
Raimund Jakesz
Austrian Breast and Colorectal Cancer Study Group
11 December 2006